Tamar Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9M | Buy |
30,381
+2,247
| +8% | +$1.18M | 1.93% | 23 |
|
|
2025
Q1 | $17.8M | Buy |
28,134
+7,733
| +38% | +$4.9M | 2.42% | 21 |
|
|
2024
Q4 | $14.5M | Buy |
20,401
+4,909
| +32% | +$3.5M | 2% | 25 |
|
|
2024
Q3 | $16.3M | Buy |
15,492
+2,211
| +17% | +$2.32M | 2.29% | 24 |
|
|
2024
Q2 | $14M | Sell |
13,281
-731
| -5% | -$768K | 2.26% | 24 |
|
|
2024
Q1 | $13.5M | Sell |
14,012
-216
| -2% | -$208K | 2.28% | 21 |
|
|
2023
Q4 | $12.5M | Buy |
14,228
+1,354
| +11% | +$1.19M | 2.45% | 19 |
|
|
2023
Q3 | $10.6M | Sell |
12,874
-166
| -1% | -$137K | 2.55% | 15 |
|
|
2023
Q2 | $9.37M | Buy |
13,040
+1,570
| +14% | +$1.13M | 2.3% | 19 |
|
|
2023
Q1 | $9.42M | Sell |
11,470
-1,180
| -9% | -$970K | 2.71% | 14 |
|
|
2022
Q4 | $9.13M | Sell |
12,650
-116
| -0.9% | -$83.7K | 2.9% | 17 |
|
|
2022
Q3 | $8.79M | Buy |
12,766
+486
| +4% | +$335K | 2.81% | 12 |
|
|
2022
Q2 | $7.26M | Buy |
12,280
+319
| +3% | +$189K | 2.38% | 18 |
|
|
2022
Q1 | $8.35M | Buy |
11,961
+1,358
| +13% | +$948K | 2.33% | 18 |
|
|
2021
Q4 | $6.7M | Sell |
10,603
-152
| -1% | -$96K | 1.97% | 24 |
|
|
2021
Q3 | $6.51M | Sell |
10,755
-76
| -0.7% | -$46K | 2.35% | 20 |
|
|
2021
Q2 | $6.05M | Buy |
10,831
+689
| +7% | +$385K | 2.33% | 19 |
|
|
2021
Q1 | $4.8M | Buy |
10,142
+1,904
| +23% | +$901K | 1.86% | 25 |
|
|
2020
Q4 | $3.98M | Buy |
8,238
+667
| +9% | +$322K | 2.26% | 19 |
|
|
2020
Q3 | $4.24M | Buy |
7,571
+472
| +7% | +$264K | 2.63% | 15 |
|
|
2020
Q2 | $4.43M | Buy |
+7,099
| New | +$4.43M | 3.53% | 8 |
|